Omada Health, Inc. (OMDA) Tops Q4 EPS by 14c, provides guidance

Omada Health, Inc. (NASDAQ: OMDA) reported Q4 EPS of $0.08, $0.14 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $75.85 million, versus $0 reported last year.

GUIDANCE:

Omada Health, Inc. sees FY2026 revenue of $312-322 million, versus the consensus of $312.2 million. Adjusted EBITDA in the range of $7 million to $15 million

For earnings history and earnings-related data on Omada Health, Inc. (OMDA) click here.

You May Also Be Interested In

• Infleqtion raises Q2 revenue to $13.5M after contract restatement
• JPMorgan Downgrades Millicom International Cellular SA (TIGO) to Neutral
• XP Inc eyes US banking license as next business step